```markdown
# TREATMENT ADHERENCE BY BIPOLAR DISORDER PATIENTS

## Table 3. Major frustrations reported by BPD patients

| Characteristic | n (%) |
| --- | --- |
| Illness-related factors | |
| Mood swings | 281 (66.4) |
| Others | 238 (56.3) |
| Depression | 184 (43.5) |
| Perception/stigma | 171 (40.4) |
| Problems with trust/relationships/social interactions | 152 (35.9) |
| Holding down a job | 118 (27.9) |
| Hobbies | 152 (35.9) |
| Highs of mood | 115 (27.2) |
| Treatment-related factors | |
| Lack of information | 26 (6.15) |
| Taking medication every day | 216 (51.0) |
| Medication side-effects | 170 (40.1) |
| Cost of treatment | 3 (0.71) |
| Other | 34 (8.04) |

Responding patients (N = 423, 98.6%) cited four major frustrations/needings of treatment longer (>23.2%) > b) no longer wanting to take it any longer (18.5%) > c) side effects (13.1%) > d) feeling better at the time (10.8%).

The rate of reported major defaulting in the past (33.9%) is similar, and the rate of missing recent doses (33.8%) and similar, and the rate of missing recent doses (33.8%) and current nonadherence (45.0%) involved the same persons. Both rates represent about one-third of all treated patients with BPD, indicating that the most common response was the need for better treatment. Some patients of treatment-sampled may be quite prevalent among contemporary American BPD patients. The apparently large disparity between physicians' impressions and patient self-reports is important for treatment-acceptance among 29.1% of their patients, and improvement of treatment-outcomes, such that physicians themselves-defined "nonadherence," likely reflect differences in definitions of "nonadherence," such that clinicians self-defined nonadherence was more likely to reflect undefined periods of risk, experienced adverse effects of psychotropic medications at some time in the past, that adverse effects of psychotropic medications were of concern to 14.0% of patients (60/429), and were considered by their physicians to be severe in 15.0% (9/60) of that subgroup. Psychiatrists reported that 30.5% of their 429 BPD patients had experienced weight-gain in association with current treatment, with substantial prevalence of hyperlipidemia (19.1%) and diabetes (8.62%) and identified these commonly cited major burdens involving mood swings (66.4%) > depression (56.3%) > need for daily self-medication (51.1%) > stigma of being considered mentally ill (43.5%) > medication side-effects (40.4%) > medication side-effects (40.2%). Prominent adverse effects associated with treatment-nonadherence, as identified by the 145 patients with PSF and PRF questionnaires, which yielded a total self-reported nonadherence, ranked: weight-gain of 59 variables tentatively related to treatment adherence, based on initial univariate comparisons (58.5%) > excessive sedation (54.2%) > physical awkwardness or tremor (33.1%).

## Univariate analyses of factors associated with treatment-nonadherence

We compared treatment-nonadherent with treatment-adherent patients on a list of factors identified in the self-reported nonadherence, as identified by the 145 patients with PSF and PRF questionnaires, ranked: weight-gain of 59 variables tentatively related to treatment adherence, based on the initial univariate comparisons (58.5%) > excessive sedation (54.2%) > weight-gain (33.1%).

Copyright Â© 2007 John Wiley & Sons, Ltd.

Hum. Psychopharmacol Clin Exp 2008; 23: 95-105.
DOI: 10.1002/hup
```